Kovack Advisors Inc. Acquires 340 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Kovack Advisors Inc. grew its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 4.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,481 shares of the biotechnology company’s stock after purchasing an additional 340 shares during the period. Kovack Advisors Inc.’s holdings in Axon Enterprise were worth $3,389,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of the business. PFG Investments LLC increased its holdings in Axon Enterprise by 0.6% in the 3rd quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock worth $1,547,000 after buying an additional 25 shares in the last quarter. Gladstone Institutional Advisory LLC boosted its holdings in shares of Axon Enterprise by 1.6% during the 3rd quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company’s stock valued at $656,000 after acquiring an additional 26 shares during the last quarter. Mather Group LLC. grew its stake in shares of Axon Enterprise by 3.7% in the third quarter. Mather Group LLC. now owns 759 shares of the biotechnology company’s stock worth $303,000 after acquiring an additional 27 shares during the period. CWM LLC lifted its position in Axon Enterprise by 1.3% during the third quarter. CWM LLC now owns 2,856 shares of the biotechnology company’s stock valued at $1,141,000 after purchasing an additional 36 shares during the period. Finally, SPC Financial Inc. lifted its position in Axon Enterprise by 2.2% during the third quarter. SPC Financial Inc. now owns 1,773 shares of the biotechnology company’s stock valued at $708,000 after purchasing an additional 38 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the stock. Jefferies Financial Group started coverage on shares of Axon Enterprise in a research note on Wednesday, July 17th. They set a “buy” rating and a $385.00 target price for the company. Robert W. Baird upped their price objective on Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. The Goldman Sachs Group raised their target price on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Northland Securities upped their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday. Finally, Bank of America initiated coverage on shares of Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $380.00 price objective on the stock. Two investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $427.83.

Axon Enterprise Price Performance

Shares of AXON stock traded up $20.64 on Wednesday, hitting $615.82. 148,475 shares of the stock traded hands, compared to its average volume of 546,276. The firm has a market cap of $46.96 billion, a price-to-earnings ratio of 153.79, a PEG ratio of 15.47 and a beta of 0.94. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The firm has a 50 day simple moving average of $423.98 and a two-hundred day simple moving average of $351.79. Axon Enterprise, Inc. has a 52 week low of $220.51 and a 52 week high of $624.84.

Insider Buying and Selling at Axon Enterprise

In other news, CEO Patrick W. Smith sold 80,300 shares of the company’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $371.78, for a total value of $29,853,934.00. Following the completion of the transaction, the chief executive officer now owns 3,015,366 shares of the company’s stock, valued at $1,121,052,771.48. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, CEO Patrick W. Smith sold 80,300 shares of the company’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the completion of the transaction, the chief executive officer now owns 3,015,366 shares in the company, valued at approximately $1,121,052,771.48. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $437.98, for a total transaction of $437,980.00. Following the completion of the sale, the director now owns 26,259 shares in the company, valued at approximately $11,500,916.82. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 369,172 shares of company stock valued at $136,270,842 over the last ninety days. 5.70% of the stock is currently owned by company insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.